ImmunoScape

ImmunoScape is discovering and developing next-generation T-cell receptor (TCR) cell therapies to treat cancer. Using their Deep Immunomics and Machine Learning platform, ImmunoScape is continuously generating unique TCR hits by mining blood and tissue samples. From here, ImmunoScape is progressing assets towards clinical candidate nomination following use of their proprietary high-throughput screening platform TargetScape. ImmunoScape’s evolving TCR portfolio encompasses several internal programs and opportunities for external partnering across different types of solid tumors.

Jobs: